Newswise News from University of Maryland School of Medicine Latest news from University of Maryland School of Medicine on Newswise en-us Copyright 2024 Newswise Newswise News from University of Maryland School of Medicine 115 31 / /images/newswise-logo-rss.gif Leading Computational Scientist and Oncology Researcher Elana Fertig, PhD, Appointed as New Director of the Institute for Genome Sciences at the University of Maryland School of Medicine /articles/leading-computational-scientist-and-oncology-researcher-elana-fertig-phd-appointed-as-new-director-of-the-institute-for-genome-sciences-at-the-university-of-maryland-school-of-medicine/?sc=rsin /articles/leading-computational-scientist-and-oncology-researcher-elana-fertig-phd-appointed-as-new-director-of-the-institute-for-genome-sciences-at-the-university-of-maryland-school-of-medicine/?sc=rsin Wed, 28 Aug 2024 12:05:53 EST University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Elana J. Fertig, PhD, FAIMBE, as the new Director of the School's Institute for Genome Sciences (IGS). University of Maryland School of Medicine Nationally Recognized Behavioral Scientist Dr. Kelly Dunn Named Director of the Kahlert Institute for Addiction Medicine at the University of Maryland School of Medicine /articles/nationally-recognized-behavioral-scientist-dr-kelly-dunn-named-director-of-the-kahlert-institute-for-addiction-medicine-at-the-university-of-maryland-school-of-medicine/?sc=rsin /articles/nationally-recognized-behavioral-scientist-dr-kelly-dunn-named-director-of-the-kahlert-institute-for-addiction-medicine-at-the-university-of-maryland-school-of-medicine/?sc=rsin Mon, 19 Aug 2024 13:05:53 EST University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Kelly Dunn, PhD, MBA, one of the nation's leading researchers on opioid use disorder, as the inaugural Director of the School's Kahlert Institute for Addiction Medicine University of Maryland School of Medicine Study: Living in Disadvantaged Neighborhoods Influences Stress-Related Genes, Which May Contribute to Aggressive Prostate Cancer in African American Men /articles/study-living-in-disadvantaged-neighborhoods-influences-stress-related-genes-which-may-contribute-to-aggressive-prostate-cancer-in-african-american-men/?sc=rsin /articles/study-living-in-disadvantaged-neighborhoods-influences-stress-related-genes-which-may-contribute-to-aggressive-prostate-cancer-in-african-american-men/?sc=rsin Thu, 15 Aug 2024 16:05:21 EST Study: Living in Disadvantaged Neighborhoods Influences Stress-Related Genes, Which May Contribute to Aggressive Prostate Cancer in African American Men University of Maryland School of Medicine Patients with Unexplainable Chronic Itch Have Unique Blood Biomarkers that Could Eventually Lead to New Targeted Treatments /articles/patients-with-unexplainable-chronic-itch-have-unique-blood-biomarkers-that-could-eventually-lead-to-new-targeted-treatments/?sc=rsin /articles/patients-with-unexplainable-chronic-itch-have-unique-blood-biomarkers-that-could-eventually-lead-to-new-targeted-treatments/?sc=rsin Wed, 14 Aug 2024 14:05:34 EST Millions of patients worldwide suffer from a chronic itching condition with no identifiable cause - a condition known as chronic pruritus of unknown origin (CPUO) - that has no targeted therapies approved to treat it. Many of these patients suffer for years with little relief, but a new University of Maryland School of Medicine study may provide hope for future treatments. Patients were found to have lower than normal levels of metabolite biomarkers in the blood plasma that could point to a cause of their excruciating symptoms. University of Maryland School of Medicine Orthopaedic Surgeon-Scientist Dr. Frank Henn Named Chair of the Department of Orthopaedics /articles/orthopaedic-surgeon-scientist-dr-frank-henn-named-chair-of-the-department-of-orthopaedics/?sc=rsin /articles/orthopaedic-surgeon-scientist-dr-frank-henn-named-chair-of-the-department-of-orthopaedics/?sc=rsin Mon, 29 Jul 2024 13:05:17 EST Dr. Henn is Established Academic Leader with Strong Track Record of Success in Research and Clinical Care; Led Department's Residency Program to Become Among Top in the Nation University of Maryland School of Medicine Faculty Physicians to Establish New Community "Health Village" at Mondawmin Mall /articles/faculty-physicians-to-establish-new-community-health-village-at-mondawmin-mall/?sc=rsin /articles/faculty-physicians-to-establish-new-community-health-village-at-mondawmin-mall/?sc=rsin Tue, 09 Jul 2024 22:05:40 EST New Leased Space Will Include Adult and Pediatric Primary Care, Mental Health Services, Prenatal Care, and Nutrition Counseling University of Maryland School of Medicine Drug Used to Treat Eczema May Provide Relief for Patients with Intensely Itchy Skin Diseases /articles/drug-used-to-treat-eczema-may-provide-relief-for-patients-with-intensely-itchy-skin-diseases/?sc=rsin /articles/drug-used-to-treat-eczema-may-provide-relief-for-patients-with-intensely-itchy-skin-diseases/?sc=rsin Wed, 05 Jun 2024 17:05:10 EST Clinical Trial Finds Oral Medication Significantly Reduced Prurigo Nodularis and Chronic Pruritus of Unknown Origin Symptoms A drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according to a new study published in JAMA Dermatology. University of Maryland School of Medicine University of Maryland School of Medicine Launches Vaccine Development Program to Prevent Sepsis in Newborns /articles/university-of-maryland-school-of-medicine-launches-vaccine-development-program-to-prevent-sepsis-in-newborns-newsarchive-pages2024-newsuniversity-of-maryland-school-of-medicine-launches-vaccine-development-program-to-prevent-sepsis-in-newborns/?sc=rsin /articles/university-of-maryland-school-of-medicine-launches-vaccine-development-program-to-prevent-sepsis-in-newborns-newsarchive-pages2024-newsuniversity-of-maryland-school-of-medicine-launches-vaccine-development-program-to-prevent-sepsis-in-newborns/?sc=rsin Tue, 21 May 2024 12:05:06 EST University of Maryland School of Medicine (UMSOM) researchers at the Center for Vaccine Development and Global Health (CVD) have been awarded $3.96 million to develop a maternal vaccine that prevents sepsis caused by Klebsiella pneumoniae in newborns and infants. University of Maryland School of Medicine Women Need Better Treatments for Bacterial Vaginosis /articles/women-need-better-treatments-for-bacterial-vaginosis/?sc=rsin /articles/women-need-better-treatments-for-bacterial-vaginosis/?sc=rsin Thu, 02 May 2024 11:00:00 EST Bacterial Vaginosis (BV) affects about one-quarter of reproductive-age women and is linked to adverse health outcomes, such as increased HIV risk. Yet for decades, BV treatment in the United States has largely relied on antibiotics, and BV recurrence is common following antibiotic therapy. University of Maryland School of Medicine UMSOM Preclinical Study Finds Novel Stem Cell Therapy Boosts Neural Repair After Cardiac Arrest /articles/umsom-preclinical-study-finds-novel-stem-cell-therapy-boosts-neural-repair-after-cardiac-arrest/?sc=rsin /articles/umsom-preclinical-study-finds-novel-stem-cell-therapy-boosts-neural-repair-after-cardiac-arrest/?sc=rsin Wed, 01 May 2024 11:05:46 EST New stem cell therapy in animal model could eventually lead to viable treatment option  Researchers at the University of Maryland School of Medicine (UMSOM) have identified an innovation in stem cell therapy to regenerate neural cells in the brain after cardiac arrest in an animal model.  University of Maryland School of Medicine University of Maryland Greenebaum Comprehensive Cancer Center and AstraZeneca Partner to Enhance Community-Based Lung Cancer Screening and Detection for Marylanders at High Risk /articles/university-of-maryland-greenebaum-comprehensive-cancer-center-and-astrazeneca-partner-to-enhance-community-based-lung-cancer-screening-and-detection-for-marylanders-at-high-risk/?sc=rsin /articles/university-of-maryland-greenebaum-comprehensive-cancer-center-and-astrazeneca-partner-to-enhance-community-based-lung-cancer-screening-and-detection-for-marylanders-at-high-risk/?sc=rsin Wed, 17 Apr 2024 13:05:04 EST With only a small percentage of Marylanders at high risk for lung cancer getting the recommended annual screening, the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) today launched a new statewide effort to increase annual screenings. University of Maryland School of Medicine Researchers Identify New Genetic Risk Factors for Persistent HPV Infections /articles/researchers-identify-new-genetic-risk-factors-for-persistent-hpv-infections22/?sc=rsin /articles/researchers-identify-new-genetic-risk-factors-for-persistent-hpv-infections22/?sc=rsin Thu, 11 Apr 2024 09:05:06 EST Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide. University of Maryland School of Medicine UMSOM Researchers Identify Safety of a Potential New Treatment to Manage Complications from Sickle Cell Disease /articles/treatment-for-lung-condition-could-help-patients-with-sickle-cell-disease-control-complications-from-hypertension-and-kidney-damage/?sc=rsin /articles/treatment-for-lung-condition-could-help-patients-with-sickle-cell-disease-control-complications-from-hypertension-and-kidney-damage/?sc=rsin Thu, 11 Apr 2024 07:05:54 EST Treatment for lung condition could help patients with sickle cell disease control complications from hypertension and kidney damage University of Maryland School of Medicine Biotechnology CEO and Inventor of SiriusXM Satellite Radio Martine Rothblatt to Deliver Graduation Address to the University of Maryland School of Medicine's 215th Graduating Class /articles/biotechnology-ceo-and-inventor-of-siriusxm-satellite-radio-martine-rothblatt-to-deliver-graduation-address-to-the-university-of-maryland-school-of-medicine-s-215th-graduating-class/?sc=rsin /articles/biotechnology-ceo-and-inventor-of-siriusxm-satellite-radio-martine-rothblatt-to-deliver-graduation-address-to-the-university-of-maryland-school-of-medicine-s-215th-graduating-class/?sc=rsin Tue, 26 Mar 2024 15:05:37 EST University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that Martine Rothblatt PhD, JD, MBA, Chairperson and CEO of United Therapeutics, and inventor of SiriusXM Satellite Radio, will deliver the keynote address for this year's graduating medical student class. The UMSOM MD graduation ceremony will take place at the Hippodrome Theatre on Thursday, May 16, 2024. University of Maryland School of Medicine New Study Reveals Insights into Lack of Durability in COVID Antibody Response to Infections and Vaccines /articles/new-study-reveals-insights-into-lack-of-durability-in-covid-antibody-response-to-infections-and-vaccines/?sc=rsin /articles/new-study-reveals-insights-into-lack-of-durability-in-covid-antibody-response-to-infections-and-vaccines/?sc=rsin Tue, 19 Mar 2024 13:40:04 EST Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the short-lived antibody response following SARS-CoV-2, the virus that causes COVID. University of Maryland School of Medicine University of Maryland, Baltimore Researchers Call for Regulation of Direct-to-Consumer Microbiome Tests /articles/university-of-maryland-baltimore-researchers-call-for-regulation-of-direct-to-consumer-microbiome-tests/?sc=rsin /articles/university-of-maryland-baltimore-researchers-call-for-regulation-of-direct-to-consumer-microbiome-tests/?sc=rsin Thu, 14 Mar 2024 14:00:00 EST Burgeoning interest in the microbiome has led to a growing demand for direct-to-consumer (DTC) microbiome testing services. University of Maryland School of Medicine People with Diabetes Who Live in Rural Areas More Likely to Develop Complications of the Disease, UM School of Medicine Study Finds /articles/people-with-diabetes-who-live-in-rural-areas-more-likely-to-develop-complications-of-the-disease-um-school-of-medicine-study-finds/?sc=rsin /articles/people-with-diabetes-who-live-in-rural-areas-more-likely-to-develop-complications-of-the-disease-um-school-of-medicine-study-finds/?sc=rsin Fri, 08 Mar 2024 10:05:04 EST It has been well established that people who live in rural areas in the U.S. are more likely to have diabetes and experience barriers to managing their condition compared to those who live in the suburbs and cities. University of Maryland School of Medicine UM School of Medicine Awarded $3.5 Million in Federal Funding to Expand Medical Countermeasures Program /articles/um-school-of-medicine-awarded-3-5-million-in-federal-funding-to-expand-medical-countermeasures-program/?sc=rsin /articles/um-school-of-medicine-awarded-3-5-million-in-federal-funding-to-expand-medical-countermeasures-program/?sc=rsin Mon, 26 Feb 2024 19:05:37 EST University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that UMSOM faculty scientists have been selected as key contractors by the Biomedical Advanced Research and Development Authority (BARDA), for the federal agency's Radiation Nuclear Animal Model Development program. University of Maryland School of Medicine UMSOM and UMB Faculty Receive $10.6 Million in State Funding for Abortion Clinical Care Training Program /articles/umsom-and-umb-faculty-receive-10-6-million-in-state-funding-for-abortion-clinical-care-training-program/?sc=rsin /articles/umsom-and-umb-faculty-receive-10-6-million-in-state-funding-for-abortion-clinical-care-training-program/?sc=rsin Wed, 21 Feb 2024 16:05:42 EST A $10.6 million training grant has been awarded to the University of Maryland School of Medicine (UMSOM) and University of Maryland, Baltimore (UMB) to administer Maryland's Abortion Clinical Care Training Program. University of Maryland School of Medicine Leading Technology Investment Executive Troy LeMaile-Stovall Appointed to University of Maryland School of Medicine Board of Visitors /articles/leading-technology-investment-executive-troy-lemaile-stovall-appointed-to-university-of-maryland-school-of-medicine-board-of-visitors/?sc=rsin /articles/leading-technology-investment-executive-troy-lemaile-stovall-appointed-to-university-of-maryland-school-of-medicine-board-of-visitors/?sc=rsin Tue, 20 Feb 2024 11:05:22 EST niversity of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, along with UMSOM Board of Visitors Chair Cynthia Egan, announced today that Troy LeMaile-Stovall, MS, MBA, an award-winning technology investment, higher education, and management consulting executive, has been appointed to the School's Board of Visitors. University of Maryland School of Medicine